SecSonar.com

Centessa Pharmaceuticals plc (CNTA)

Centessa Pharmaceuticals plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Centessa Pharmaceuticals plc (CNTA) is a Biotechnology company based in GB with a market capitalization of $6.1B. Free cash flow was negative at -$194.2M. This page tracks CNTA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 77 employees · IPO May 28, 2021

Valuation

Valuation & price

$39.78 · as of May 26, 2026 · -1.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

11.67

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$40.50$27.06$13.62Jul 25Dec 25Jun 26Jul 7, 25$13.62Jul 9, 25$14.03Jul 11, 25$14.43Jul 15, 25$15.08Jul 17, 25$15.96Jul 21, 25$16.06Jul 23, 25$15.57Jul 25, 25$15.41Jul 29, 25$15.21Jul 31, 25$17.17Aug 4, 25$16.08Aug 6, 25$17.14Aug 8, 25$17.02Aug 12, 25$17.11Aug 14, 25$17.64Aug 18, 25$17.59Aug 20, 25$17.28Aug 22, 25$17.01Aug 27, 25$16.65Aug 29, 25$16.79Sep 3, 25$15.91Sep 5, 25$15.73Sep 9, 25$20.85Sep 11, 25$22.67Sep 15, 25$22.02Sep 17, 25$21.85Sep 19, 25$22.79Sep 23, 25$23.34Sep 25, 25$23.01Sep 29, 25$24.40Oct 1, 25$22.62Oct 3, 25$23.23Oct 7, 25$23.12Oct 9, 25$22.83Oct 13, 25$22.47Oct 16, 25$22.86Oct 20, 25$22.79Oct 22, 25$23.28Oct 24, 25$24.15Oct 28, 25$25.00Oct 30, 25$24.33Nov 3, 25$23.94Nov 5, 25$22.52Nov 7, 25$22.12Nov 11, 25$22.54Nov 13, 25$25.97Nov 17, 25$27.32Nov 19, 25$28.00Nov 21, 25$27.98Nov 25, 25$28.96Nov 28, 25$29.03Dec 2, 25$28.51Dec 5, 25$29.91Dec 9, 25$28.60Dec 11, 25$27.18Dec 15, 25$26.15Dec 17, 25$24.98Dec 19, 25$24.85Dec 23, 25$25.26Dec 26, 25$25.33Dec 30, 25$24.74Jan 2, 26$23.69Jan 6, 26$22.68Jan 8, 26$22.05Jan 12, 26$22.02Jan 14, 26$22.09Jan 16, 26$22.20Jan 21, 26$23.23Jan 23, 26$25.27Jan 28, 26$25.24Jan 30, 26$24.57Feb 3, 26$25.48Feb 5, 26$23.54Feb 9, 26$23.53Feb 11, 26$23.56Feb 13, 26$24.71Feb 18, 26$25.04Feb 20, 26$24.50Feb 24, 26$26.52Feb 26, 26$26.77Mar 2, 26$26.51Mar 4, 26$26.70Mar 6, 26$25.95Mar 10, 26$27.59Mar 12, 26$27.22Mar 16, 26$28.29Mar 19, 26$28.34Mar 23, 26$25.94Mar 25, 26$28.22Mar 27, 26$28.70Mar 31, 26$39.72Apr 2, 26$39.69Apr 7, 26$39.55Apr 9, 26$39.76Apr 13, 26$39.57Apr 15, 26$39.61Apr 17, 26$39.66Apr 21, 26$39.49Apr 23, 26$39.43Apr 27, 26$39.51Apr 29, 26$39.45May 1, 26$39.57May 5, 26$39.67May 8, 26$39.59May 12, 26$39.61May 14, 26$39.60May 18, 26$39.64May 20, 26$39.75May 22, 26$39.75May 27, 26$39.77May 29, 26$39.76Jun 2, 26$39.90Jun 4, 26$39.80Jun 8, 26$39.70Jun 10, 26$39.69Jun 12, 26$39.72Jun 16, 26$39.75Jun 18, 26$40.02Jun 23, 26$40.50Jun 29, 26$40.50
$13.5652-week range$40.50
Loading valuation history…

Fundamentals

Key fundamentals

$6.1B

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$194.2M

Free cash flow (USD)

-$287M

Net debt

Net cash position

18.6%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$6.9MFY 2024$0.00FY 2025$15.0M
$0$15M

Free cash flow by year

2019 → 2025

FY 2019$-5.8MFY 2020$-10.6MFY 2021$-136.3MFY 2022$-201.7MFY 2023$-160.5MFY 2024$-142.1MFY 2025$-194.2M
-$5.8M-$194.2M

Gross margin by year

2023 → 2025

FY 2023100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

2

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 5, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider sellInsider SellINDEX VENTURES LIFE VI (JERSEY) L.P. · 10% OwnerJun 24, 2026Filing
  • Insider sellInsider SellMedicxi Ventures Management (Jersey) Ltd · 10% OwnerJun 24, 2026Filing
  • 8-K eventAcquisition CompletedJun 24, 2026Filing
  • 8-K eventShareholder Meetings HeldJun 12, 2026Filing
  • 8-K eventAcquisition UpdateMay 22, 2026Filing
  • Quarterly report10-Q FiledMay 5, 2026Filing
  • 8-K eventAcquisition AnnouncedMar 31, 2026Filing
  • Annual report10-K FiledMar 31, 2026Filing

Questions

Frequently asked questions

What is Centessa Pharmaceuticals plc's market cap?

Centessa Pharmaceuticals plc (CNTA) has a market capitalization of $6.1B.

What is CNTA's P/E ratio?

A meaningful P/E ratio is not available for CNTA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CNTA's price-to-book (P/B) ratio?

CNTA trades at 11.67 times book value per share.

Are insiders buying CNTA stock?

SEC Form 4 filings show no open-market insider buys at Centessa Pharmaceuticals plc in the last 90 days (2 sells).

Same arena

Related companies in Biotechnology

PTCT

PTC Therapeutics, Inc.

$6.1B

RYTM

Rhythm Pharmaceuticals, Inc.

$6.2B

PTGX

Protagonist Therapeutics, Inc.

$6.4B

TGTX

TG Therapeutics, Inc.

$5.9B

KYMR

Kymera Therapeutics, Inc.

$6.7B

LQDA

Liquidia Corporation

$5.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.